NCT03249545

Brief Summary

Premature Ventricular Complex (PVC) ablation is performed in certain indications. Generally acutely abolition of PVC at the time of ablation accepted as successful ablation. However in some patients this effect occurs lately. In this study investigators sought late effect of ablation

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 6, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 15, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

August 15, 2017

Status Verified

August 1, 2017

Enrollment Period

1.5 years

First QC Date

August 6, 2017

Last Update Submit

August 9, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success

    Continuation of ablation on the long term

    3 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals having premature complexes and matching ablation indications are included and selection will be based on above mentioned criteria

You may qualify if:

  • Patients who had both of the criteria below
  • Presence of premature ventricular complex requiring ablation
  • Successfully abolition of premature ventricular complex hours after the procedure

You may not qualify if:

  • Patients who had either of below mentioned criteria
  • Abolition of premature ventricular complex during the procedure
  • Unsuccessful procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Turkiye Yuksek Ihtisas Training and Research Hospital

Ankara, 06590, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Ventricular Premature Complexes

Condition Hierarchy (Ancestors)

Cardiac Complexes, PrematureArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Firat Ozcan, Ass. Prof, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,Associate Profesor

Study Record Dates

First Submitted

August 6, 2017

First Posted

August 15, 2017

Study Start

July 1, 2017

Primary Completion

December 31, 2018

Study Completion

March 1, 2019

Last Updated

August 15, 2017

Record last verified: 2017-08

Locations